<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Commercialization (Phase I Summary)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I commercialization summary: customer, market, product, pricing, go-to-market, and milestones." />

  <style>
    * { box-sizing: border-box; }
    html, body { height: 100%; }

    body {
      margin: 0;
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background: #020617;
      color: #e5e7eb;
      line-height: 1.55;
    }

    a { color: inherit; text-decoration: none; }

    .page {
      min-height: 100vh;
      display: flex;
      flex-direction: column;
    }

    header {
      position: sticky;
      top: 0;
      z-index: 20;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.25);
    }

    .nav {
      max-width: 1120px;
      margin: 0 auto;
      padding: 14px 20px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      gap: 20px;
      flex-wrap: wrap;
    }

    .nav-left {
      display: flex;
      align-items: center;
      gap: 12px;
    }

    .logo-dot {
      width: 28px;
      height: 28px;
      border-radius: 999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow: 0 0 18px rgba(56,189,248,.7);
      flex: 0 0 auto;
    }

    .brand {
      font-size: 1.05rem;
      font-weight: 700;
      letter-spacing: 0.04em;
      line-height: 1.1;
    }

    .brand-sub {
      font-size: .72rem;
      color: #9ca3af;
      margin-top: 2px;
    }

    .nav-links {
      display: flex;
      gap: 10px;
      font-size: .88rem;
      color: #9ca3af;
      flex-wrap: wrap;
      justify-content: center;
    }

    .nav-links a {
      padding: 6px 10px;
      border-radius: 999px;
      border: 1px solid transparent;
    }

    .nav-links a:hover {
      color: #e5e7eb;
      background: rgba(148, 163, 184, 0.14);
      border-color: rgba(148, 163, 184, 0.18);
    }

    .nav-links a.active {
      color: #e5e7eb;
      background: rgba(148, 163, 184, 0.18);
      border-color: rgba(148, 163, 184, 0.22);
    }

    .nav-cta {
      display: flex;
      gap: 10px;
      align-items: center;
      margin-left: auto;
    }

    .btn {
      border-radius: 999px;
      border: 1px solid rgba(148, 163, 184, 0.55);
      padding: 8px 14px;
      font-size: .85rem;
      cursor: pointer;
      background: transparent;
      color: #e5e7eb;
      display: inline-block;
      white-space: nowrap;
    }

    .btn-primary {
      border: none;
      background: linear-gradient(135deg,#22c55e,#22d3ee,#6366f1);
      color: #020617;
      font-weight: 650;
      box-shadow: 0 0 22px rgba(59,130,246,0.45);
    }

    .btn-primary:hover { filter: brightness(1.05); }
    .btn-outline:hover { background: rgba(148, 163, 184, 0.18); }

    main { flex: 1; }

    .section {
      max-width: 1120px;
      margin: 0 auto;
      padding: 34px 20px;
    }

    .hero { padding-top: 30px; padding-bottom: 16px; }

    .badge-row {
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
      margin-bottom: 14px;
    }

    .badge {
      font-size: .7rem;
      text-transform: uppercase;
      letter-spacing: .12em;
      border-radius: 999px;
      padding: 5px 11px;
      border: 1px solid rgba(251,191,36,0.55);
      color: #fed7aa;
      background: rgba(120,53,15,0.35);
    }

    .badge.info {
      border-color: rgba(56,189,248,0.55);
      color: #bae6fd;
      background: rgba(15,23,42,0.9);
    }

    .title {
      font-size: clamp(1.9rem, 2.2vw + 1.2rem, 2.55rem);
      font-weight: 780;
      letter-spacing: 0.01em;
      color: #f9fafb;
      margin: 10px 0 10px;
      line-height: 1.15;
    }

    .lede {
      font-size: 1.02rem;
      color: #e5e7eb;
      max-width: 58rem;
      margin: 0 0 14px;
    }

    .meta {
      font-size: .84rem;
      color: #9ca3af;
      margin-top: 10px;
    }

    .grid {
      display: grid;
      grid-template-columns: minmax(0,1fr) minmax(0,1fr);
      gap: 18px;
      margin-top: 18px;
      align-items: start;
    }

    .grid-3 {
      display: grid;
      grid-template-columns: minmax(0,1fr) minmax(0,1fr) minmax(0,1fr);
      gap: 18px;
      margin-top: 18px;
      align-items: start;
    }

    .card {
      border-radius: 16px;
      padding: 16px 18px;
      background: rgba(15,23,42,0.92);
      border: 1px solid rgba(55,65,81,0.85);
      box-shadow: 0 18px 35px rgba(15,23,42,0.55);
    }

    .kicker {
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 6px;
    }

    h2 {
      margin: 0 0 10px;
      font-size: 1.18rem;
      color: #f9fafb;
      letter-spacing: 0.01em;
    }

    p { margin: 0 0 10px; color: #d1d5db; font-size: .94rem; }

    ul {
      padding-left: 1.1rem;
      margin: 8px 0 0;
      color: #d1d5db;
      font-size: .92rem;
    }

    li { margin-bottom: 6px; }

    .callout {
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148, 163, 184, 0.5);
      background: rgba(2,6,23,0.35);
      font-size: .9rem;
      color: #e5e7eb;
      margin-top: 10px;
    }
    .callout strong { color: #22c55e; }

    .mini { font-size: .82rem; color: #9ca3af; margin-top: 8px; }

    .pill {
      display: inline-block;
      font-size: .72rem;
      padding: 4px 8px;
      border-radius: 999px;
      background: rgba(15,23,42,0.9);
      border: 1px solid rgba(129,140,248,0.45);
      color: #c7d2fe;
      margin: 2px 6px 2px 0;
      white-space: nowrap;
    }

    footer {
      border-top: 1px solid rgba(31,41,55,0.9);
      padding: 16px 20px 22px;
      font-size: .78rem;
      color: #6b7280;
      text-align: center;
      background: #020617;
    }

    @media (max-width: 980px) {
      .grid, .grid-3 { grid-template-columns: minmax(0,1fr); }
      .nav-cta { margin-left: 0; width: 100%; justify-content: flex-start; }
      .nav { gap: 12px; }
    }
  </style>
</head>

<body>
<div class="page">

  <!-- HEADER -->
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="brand-sub">Commercialization (Phase I Summary)</div>
        </div>
      </div>

      <nav class="nav-links">
        <a href="sbir.html">SBIR Landing</a>
        <a href="aims.html">Specific Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html" class="active">Commercialization</a>
      </nav>

      <div class="nav-cta">
        <a class="btn btn-outline" href="mailto:dohoon.kim1@icloud.com?subject=PromptGenix%20Commercialization%20Inquiry">Email</a>
        <a class="btn btn-primary" href="#gtm">Go-to-Market</a>
      </div>
    </div>
  </header>

  <main>

    <!-- HERO -->
    <section class="section hero">
      <div class="badge-row">
        <span class="badge">Phase I</span>
        <span class="badge info">Customer discovery ready</span>
        <span class="badge info">On-prem or AWS VPC</span>
      </div>

      <h1 class="title">Commercialization Summary</h1>
      <p class="lede">
        PromptGenix is a BioAI automation platform that turns RNA-Seq and flow cytometry inputs into reproducible
        pipelines, reviewer-ready reports, and a PubMed-aware <strong>Hypothesis Generator</strong> that proposes
        testable hypotheses and concrete validation experiments. Commercialization targets NIH-funded labs, government
        research groups, and CROs that need faster, reproducible, interpretation-driven analysis.
      </p>

      <div class="meta">
        Contact: <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a> · Women & Minority-Owned small business positioning
      </div>
    </section>

    <!-- CUSTOMER + PROBLEM + VALUE -->
    <section class="section">
      <div class="grid">
        <div class="card">
          <div class="kicker">Target customers</div>
          <h2>Who pays and why</h2>
          <ul>
            <li><strong>NIH-funded academic labs</strong> (immunology, infectious disease, vaccines)</li>
            <li><strong>Government research groups</strong> needing on-prem, controlled workflows</li>
            <li><strong>CROs / translational teams</strong> seeking faster turnaround and standardized reporting</li>
          </ul>
          <div class="callout">
            <strong>Primary buyer:</strong> PI / lab director (budget owner).<br/>
            <strong>Primary user:</strong> analyst, bioinformatician, or senior trainee.
          </div>
        </div>

        <div class="card">
          <div class="kicker">Pain points</div>
          <h2>What breaks today</h2>
          <ul>
            <li>Tool fragmentation (alignment/QC, flow gating, enrichment, reporting)</li>
            <li>Manual scripting and inconsistent reproducibility</li>
            <li>Weeks of turnaround and difficult onboarding of new analysts</li>
            <li>Interpretation burden (literature reading, mechanistic framing)</li>
          </ul>
          <div class="callout">
            <strong>Result:</strong> slow study iteration, delayed hypothesis formation, and inconsistent outputs.
          </div>
        </div>
      </div>

      <div class="card" style="margin-top:18px;">
        <div class="kicker">Value proposition</div>
        <h2>Automation + interpretation + hypothesis (not just plots)</h2>
        <ul>
          <li><strong>Reproducible pipelines:</strong> versioned configs + deterministic outputs + standardized reports</li>
          <li><strong>AI co-investigator:</strong> structured summaries and ranked hypotheses with PubMed-linked evidence</li>
          <li><strong>Deployment options:</strong> on-prem (local) or secure AWS VPC for compliant workflows</li>
        </ul>
        <div class="mini">
          Phase I establishes technical feasibility and trust through public-data validation and traceable reporting.
        </div>
      </div>
    </section>

    <!-- PRODUCT + DIFFERENTIATION -->
    <section class="section">
      <div class="grid">
        <div class="card">
          <div class="kicker">Product</div>
          <h2>What is sold</h2>
          <p>
            PromptGenix is delivered as a packaged workflow + reporting system that can run on a local workstation
            or in a cloud environment. The platform produces exportable HTML/PDF reports with methods, figures,
            key findings, and a structured hypothesis section.
          </p>
          <div style="margin-top:10px;">
            <span class="pill">RNA-Seq pipelines</span>
            <span class="pill">Flow cytometry workflows</span>
            <span class="pill">Reports (HTML/PDF)</span>
            <span class="pill">Hypothesis Generator</span>
          </div>
        </div>

        <div class="card">
          <div class="kicker">Differentiation</div>
          <h2>Why PromptGenix wins</h2>
          <ul>
            <li><strong>End-to-end:</strong> integrates analysis + reporting + interpretation</li>
            <li><strong>Traceability:</strong> citations and evidence linkage for scientific claims</li>
            <li><strong>Actionability:</strong> experiment suggestions aligned to real lab constraints</li>
            <li><strong>Security posture:</strong> on-prem execution option for sensitive programs</li>
          </ul>
          <div class="callout">
            <strong>SBIR fit:</strong> Phase I reduces technical risk and accelerates Phase II pilots and adoption.
          </div>
        </div>
      </div>
    </section>

    <!-- PRICING + BUSINESS MODEL -->
    <section class="section">
      <div class="grid-3">
        <div class="card">
          <div class="kicker">Business model</div>
          <h2>SaaS + Enterprise options</h2>
          <ul>
            <li>Annual subscription per lab / team</li>
            <li>Optional compute add-on (cloud)</li>
            <li>Professional services for onboarding</li>
          </ul>
        </div>

        <div class="card">
          <div class="kicker">Pricing (initial)</div>
          <h2>Simple and scalable</h2>
          <ul>
            <li><strong>Starter:</strong> small lab, on-prem workflows</li>
            <li><strong>Pro:</strong> multi-project + reporting templates</li>
            <li><strong>Enterprise:</strong> VPC / compliance + support</li>
          </ul>
          <div class="mini">Exact pricing will be refined during Phase I customer discovery.</div>
        </div>

        <div class="card">
          <div class="kicker">Early revenue</div>
          <h2>Phase II readiness</h2>
          <ul>
            <li>Pilot conversions (subscription)</li>
            <li>Institutional site licenses</li>
            <li>CRO workflow packaging</li>
          </ul>
        </div>
      </div>
    </section>

    <!-- GO-TO-MARKET -->
    <section class="section" id="gtm">
      <div class="card">
        <div class="kicker">Go-to-market</div>
        <h2>Phase I customer discovery + Phase II pilots</h2>
        <p>
          Phase I will conduct structured customer discovery with PIs, analysts, and core facilities to refine
          product requirements, deployment expectations, and pricing. Phase II will focus on expanded pilots and
          adoption in real study pipelines.
        </p>

        <div class="grid" style="margin-top:14px;">
          <div class="card" style="box-shadow:none;">
            <div class="kicker">Phase I (now)</div>
            <ul>
              <li>10–20 discovery interviews (PI/analyst/core)</li>
              <li>2–3 pilot partners for usability scoring (public/de-identified)</li>
              <li>Refine “Hypothesis usefulness” rubric and reporting formats</li>
            </ul>
          </div>

          <div class="card" style="box-shadow:none;">
            <div class="kicker">Phase II (next)</div>
            <ul>
              <li>Expanded pilots (multi-site cohorts)</li>
              <li>Production-grade deployment options (on-prem / VPC)</li>
              <li>Commercial subscriptions and institutional licensing</li>
            </ul>
          </div>
        </div>

        <div class="callout">
          <strong>Channel strategy:</strong> NIH study networks, PI referrals, core facilities, and government research collaborations.
        </div>
      </div>
    </section>

    <!-- MILESTONES -->
    <section class="section">
      <div class="card">
        <div class="kicker">Milestones</div>
        <h2>Commercial readiness checkpoints</h2>
        <ul>
          <li><strong>M1:</strong> Phase I prototype validated on ≥3 public datasets (reproducibility + speed)</li>
          <li><strong>M2:</strong> Hypothesis Generator produces traceable, actionable hypotheses with citations</li>
          <li><strong>M3:</strong> Pilot partners confirm usability and value (structured rubric)</li>
          <li><strong>M4:</strong> Phase II pilot plan + pricing model refined from discovery interviews</li>
        </ul>

        <div style="margin-top:12px;display:flex;gap:10px;flex-wrap:wrap;">
          <a class="btn btn-outline" href="approach.html">Back to Approach</a>
          <a class="btn btn-primary" href="mailto:dohoon.kim1@icloud.com?subject=PromptGenix%20Pilot%20/LOS%20Request">
            Request pilot / Letter of Support
          </a>
        </div>
      </div>
    </section>

  </main>

  <footer>
    PromptGenix &middot; Commercialization (Phase I Summary) &middot;
    Contact: <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
